Literature DB >> 10493177

Characterization of the human antiporcine immune response: a prerequisite to xenotransplantation.

A L Bothwell1.   

Abstract

Successful xenotransplantation necessitates solving problems of hyperacute rejection and understanding the cellular immune responses that occur. Considerable progress has been made in our understanding of the molecular genetic basis of the rapid hyperacute antibody-mediated rejection mechanisms that occur in xenogeneic organ rejection. In parallel, strategies involving the use of transgenic animals expressing complement inhibitors are beginning to offer encouraging evidence that hyperacute rejection can be overcome. A greater understanding of cell-mediated immune interactions is now required to achieve long-term xenograft survival. Current studies are focused on T cell receptor (TCR)/major histocompatibility complex (MHC) and costimulatory signals that activate human CD4 and CD8 T cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10493177     DOI: 10.1007/BF02786491

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  40 in total

1.  CD58 and CD59 molecules exhibit potentializing effects in T cell adhesion and activation.

Authors:  M Deckert; J Kubar; A Bernard
Journal:  J Immunol       Date:  1992-02-01       Impact factor: 5.422

2.  Break for SCIDs.

Authors:  D E Mosier; R J Gulizia; B E Torbett; S M Baird; D B Wilson
Journal:  Nature       Date:  1991-10-10       Impact factor: 49.962

3.  Molecular cloning of the rat analogue of human CD59: structural comparison with human CD59 and identification of a putative active site.

Authors:  N K Rushmere; R A Harrison; C W van den Berg; B P Morgan
Journal:  Biochem J       Date:  1994-12-01       Impact factor: 3.857

Review 4.  Effector mechanisms in allograft rejection.

Authors:  D W Mason; P J Morris
Journal:  Annu Rev Immunol       Date:  1986       Impact factor: 28.527

5.  Complementary DNA sequence and deduced peptide sequence for CD59/MEM-43 antigen, the human homologue of murine lymphocyte antigen Ly-6C.

Authors:  R Sawada; K Ohashi; K Okano; M Hattori; N Minato; M Naruto
Journal:  Nucleic Acids Res       Date:  1989-08-25       Impact factor: 16.971

6.  Human coronary transplantation-associated arteriosclerosis. Evidence for a chronic immune reaction to activated graft endothelial cells.

Authors:  R N Salomon; C C Hughes; F J Schoen; D D Payne; J S Pober; P Libby
Journal:  Am J Pathol       Date:  1991-04       Impact factor: 4.307

7.  CD59 molecule: a second ligand for CD2 in T cell adhesion.

Authors:  M Deckert; J Kubar; D Zoccola; G Bernard-Pomier; P Angelisova; V Horejsi; A Bernard
Journal:  Eur J Immunol       Date:  1992-11       Impact factor: 5.532

8.  Human T-cell-mediated destruction of allogeneic dermal microvessels in a severe combined immunodeficient mouse.

Authors:  A G Murray; P Petzelbauer; C C Hughes; J Costa; P Askenase; J S Pober
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

9.  CD59 costimulation of T cell activation. CD58 dependence and requirement for glycosylation.

Authors:  E Menu; B C Tsai; A L Bothwell; P J Sims; B E Bierer
Journal:  J Immunol       Date:  1994-09-15       Impact factor: 5.422

10.  Xenogeneic skin graft rejection is especially dependent on CD4+ T cells.

Authors:  R N Pierson; H J Winn; P S Russell; H Auchincloss
Journal:  J Exp Med       Date:  1989-09-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.